Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
However, healthcare providers should still consider patient medication history to ensure safe and effective treatment with this injectable solution
Most research is on rats and mice
Research Applications Maximum GH pulse amplitude studies: When peak somatotroph stimulation is the primary endpoint, GHRP-2 delivers values the other two cant match IGF-1 axis research: Robust and sustained GH elevation drives sustained IGF-1 upregulation useful in models tracing the complete GHIGF-1tissue signaling cascade Metabolic models: Body composition, adipose tissue lipolysis, and insulin sensitivity studies in diet-induced obesity where HPA co-activation is either controlled for or informative GHSR-1a pharmacology: Receptor characterization in knockout or mutant models where potent full-agonist engagement is needed to saturate the receptor Cardiac research: Preclinical evidence for GHSR-1a-mediated cardioprotective effects potentially through PI3K/Akt survival signaling in cardiomyocytes, independent of GH elevation GHRP-6: The Original Ghrelin Mimetic GHRP-6 is the compound that started all of this
Semaglutide produced about 15% average body-weight loss in the STEP trials over 68 weeks (Wilding et al., N Engl J Med, 2021)
Parallel to this, Semaglutide also has immunogenic properties of high potential to produce anti-Semaglutide antibodies
US$ 21.30
US$ 19.99
US$ 29.10
